AccessPak for HIV PEP Expanded with Kaletra and Clarinex-D
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Clarinex-D and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: desloratadine / pseudoephedrine
Brand name: Clarinex-D 12 Hour, Clarinex-D 24 Hour
Synonyms: Desloratadine and pseudoephedrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Clarinex-D 12 Hour
- AccessPak for HIV PEP Expanded with Kaletra-Clarinex-D 24 Hour
- AccessPak for HIV PEP Expanded with Kaletra-Clarithromycin
- AccessPak for HIV PEP Expanded with Kaletra-Clarithromycin ER
- AccessPak for HIV PEP Expanded with Kaletra-Clarithromycin Extended-Release Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Clarithromycin Oral Suspension
- Clarinex-D-AccessPak for HIV PEP Expanded with Viracept
- Clarinex-D-Accolate
- Clarinex-D-Accretropin
- Clarinex-D-Accucaine
- Clarinex-D-AccuHist Drops
- Clarinex-D-AccuHist PDX Drops